INTRODUCTION
Polymers are macro molecules made up of repeating units called "monomers" joined by the same type of linkage. Starch cellulose & rubber all possesses polymeric properties. Man made polymers have been studied since 1832. We are surrounded by polymers every day, every where. 1 We wear clothes containing polyester & nylon fibers, food packaged in polyethylene container, pipe, walk on carpets made of polyolefin & sleep on mattresses made of poly urethane foam. Polyglycolic acid (PGA) was such a polymer, used in surgical sutures by surgeons.Many biomaterials, especially heart valve replacement & blood vessels are made of polymers like Dacron, Teflon & polyurethane. In 1950, synthetic organic polymers were first used as ion exchange resins for the separation of pharmaceutical products .
Polumeres (having many parts), Johan JaKob Berzelius introduced this term in 1830.since most of the functional groups present are carboxylic acid esters, thus quite logically, these macromolecules belong to the class of polymers known as polyesters. 2 A typical polymer consists of more than 10,000 atoms. Macromolecules are so common in everyday life that people hardly notice their presence. Chemists have learned how to manufacture macromolecules in the lab, but nature masters the techniques eons ago. All living cells produce a complex array of different types of macromolecules. Plants and animals contain a rich variety of biochemical macromolecules. 3 Polymers (Greek-POLY…many and MEROS…parts) are macromolecules made up of repeating units called "monomers" joined by the same type of linkage. The suffix in polymer "mer" is originated from Greek word meros which means part. The word polymer is thus coined to mean material consisting of many parts/mers. Most of the polymers are basically organic compounds, however they can be inorganic (e.g. silicones based on Si-O network). 4 Synthetic polymers are of increasing interest in drug delivery as therapeutic agent. Polymers show usually an improved pharmacokinetics compared to small molecule drugs with longer circulation time and the potential for tissue targeting. Synthetic polymers are being used as drug delivery systems as a
ABSTRACT:
The pharmaceutical industry is evaluating modes of delivery for their prized therapeutics at every step of the design cycle. In recent years, pH dependent drug delivery systems have focused much for specific purposes. Synthesis of pH dependent polymer in different monomeric ratio was intended to be used for controlled drug delivery systems. Previously synthesized monomers i. polymeric drug itself or in combination with small molecule drugs or with bio macromolecules such as proteins and poly (nucleic acids). 5 In 1970, yolles & coworker demonstrated lactic acid based polymer used for controlled drug delivery of steroids, opening grounds for the exciting fields of polymeric drug delivery. Controlled drug delivery occurs, when a polymer is judiciously combined with a drug or other active agent in such a way that the active agent is released from the material in a predesigned manner. 6 In controlled drug delivery systems designed for long term administration the drug level remaining constant, between the desired maximum & minimum, for an extended period of time. Pharmaceutical applications of polymers range from their use as binders in tablets to viscosity & flow controlling agents in liquids, suspensions & emulsions polymers can be used as film coatings to disguise the unpleasant taste of a drug, to enhance drug stability & to modify drug release characters. Advantages of controlled release devices possibly include delivery to the required site, delivery at the required rate, reduced dangers of overdose or Side effects. 7, 8 Microcapsules are a small sphere with a uniform wall around it. Most microcapsule has diameters b/w a few micro meters & a few millimeters. 9 Micro-encapsulations can be used to slow release of a drug into the body. This may permit one controlled release dose to substitute for several doses of non-encapsulated drug & also may decrease toxic side effects for some drug & by preventing high initial concentration in the blood, morphology of polymer matrix play an important role in governing the release characteristic of the encapsulated drug. 10 Polymer matrix could be formulated as micro/nanospheres, gel film or an extruded shape. The shape of extruded polymer can be important to the drug release kinetics. Zero order kinetics be achieved using a hemispherical polymer form. Polymeric drug delivery products can be formulated with excipients added to the polymer matrix. 11 The main objective of having excipients in the polymer either to modulate the drug release or to stabilize the drug or to modulate the polymer degradation kinetics 12 .
Enteric coatings consist of pH sensitive polymers which are unionized at low pH (in stomach); at high pH (in intestine) the polymers ionize causing swelling, or dissolving of the polymer. Formulation that can not the rate & period of drug delivery & target specific areas of the body treatment become increasingly & complex. 13 Challenges to not only development of new treatments but also the mechanism with which to administer them. 
Purification and polymerization of monomers
Monomers which are previously synthesized i.e.; Ethylmethacrylate and acrylic acid were distilled under vacuum with 1 gm of hydroquinone (as polymerization inhibitor) was added to it. This mixture was heated for 1hr at 40 o C then distilled off under reduced pressure of 15 mbar. This reaction mixture was distilled at 99 o C & purified monomers were collected on an ice bath & stored in refrigerator.
Polymers were prepared by using solution polymerization technique and mechanism involved is free radical mechanism. The polymers were prepared in a test tube, 5 ml THF (as a solvent) and AIBN (as initiator) and specific molar quantities of monomers as mentioned in table (1) was taken. This mixture was agitated properly for 5 min, and then N 2 gas was slowly purged to this reaction mixture for 5 min and was kept in thermostat water bath at 65 0 C over night (15-16 hrs) . After 15-16 hrs the polymer was synthesized, this was in solution form. The precipitated polymers were dried at room temperature and stored. EMA & AA were used in combination for polymerization.
Swelling studies of synthesized polymers in different pH.
For swelling studies, in different pH buffer solutions i.e; Hydrochloric acid buffer pH 1.2, Hydrochloric acid buffer pH 2.0, Phosphate buffer pH 6.0, Phosphate buffer pH 7.4, Phosphate buffer pH 7.8, Phosphate buffer pH 8.0.These different pH buffer solutions were prepared according to Indian Pharmacopoeia 2007. Films of above polymers were prepared. For swelling studies, 15 ml of each of the above buffer was taken in four different test tubes for each polymer. Approximately 5-6 mm 2 in size and 10-15 mg in weight polymeric films were placed in each test tube. The changes in films in phosphate buffer (pH 7.4, and pH 8.0), after 15, 30, 45, 60, 90,120 minutes were noted (table 1, 2). In buffer (pH 6.0, pH2.0,and pH 1.2) the changes were noted after 1 hour,2 hour, 2days,3 days,4 days,5 days,6 days,7 days(table 3,4,5 ).Swelling ratio(Q) was calculated by the formula: W w -W D /W D × 100. Where W D =Dry (initial) weight of polymeric film (mg), Ww (final) weight of polymeric film (mg).
Microencapsulation of model drug
Paracetamol (Ranbaxy pharmaceutical Ltd) drug was taken as model drug for microencapsulation. 100 mg of microspheres crushed & totally dissolved in a 100 ml solution containing 1 volume phosphate buffer (pH 7.4) & 1volume methanol & further diluted with buffer. The drug was estimated by UV spectrophotometer at 249 nm using a calibration curve based on standard solutions. The percentage of Paracetamol encapsulated with respect to total amount of Paracetamol encapsulation taken loading efficacy.
In vitro dissolution release of Paracetamol from micro spheres was evaluated using paddle dissolution apparatus. Dissolution media was 900 ml phosphate buffer (pH 7. The values given in brackets are molar quantity of monomers. The values given in brackets are molar quantity of monomers.
Drug Content of Microspheres
The drug content in microspheres of co polymer MMA (0. 
